NASP25 reflections
The rise of cell and gene therapies, the expanding needs of rare disease patients, and the importance of authentic communication in specialty pharmacy.
From tasks to people: how AI vendors are reframing the automation conversation
At this year's NASP annual meeting, AI wasn't just present—it dominated the conversation. Read my summary to get my key takeaways on what I experienced, especially leading a star-studded panel.
Hypertension: how community pharmacists could save 100,000 lives
Hypertension is killing more Americans than most chronic conditions, and yet it’s one of the cheapest and easiest to detect and treat…
Books, Bavarian foothills, and the brave new world of AI
Planning your summer reading list? Here’s a timely roundup of AI-fueled books that every exec should consider, from power plays at OpenAI to tech’s uneasy marriage with global politics.
What Asembia 2025 revealed…
What’s next for specialty pharmacy? At Asembia 2025, two themes dominated: broken hub models and the rising cost risk of gene therapies. Here’s what we learned—and what industry leaders should be doing now.